Rite Aid Wins Ruling Narrowing Claims in Generic Drug Price Case

A federal district court has dismissed most claims against Rite Aid Corp. in a suit alleging the pharmacy chain overcharged insured customers for generic drugs.

A putative class action lawsuit alleged the company used its Rx Savings Program to overcharge customers with public or private insurance for generic drugs.

The two customers, Bryon Stafford and Robert Josten, whose suits were consolidated, argued that Rite Aid illegally reported higher than their “usual and customary” generic drug prices to insurers, resulting in higher co-payments, and in insured customers paying more than customers who paid in cash.

The plaintiffs alleged that this scheme ...